Alzheimer'S Disease Clinical Trials in Glendale, AZ

Alzheimer'S Disease Clinical Trials in Glendale, AZ

View the best 10 alzheimer's disease medical studies in Glendale, Arizona. Access promising new therapies by applying to a Glendale-based Alzheimer'S Disease clinical trial.

Trials in Glendale, Arizona

Here are the top 10 medical studies for alzheimer's disease in Glendale, Arizona

Image of Clinical Research Site in Toms River, United States.

AXS-05 +1 More

NMDA receptor antagonist

Verified
Recruiting1 awardPhase 3
This trial is testing a new medication called AXS-05 to see if it can help reduce agitation in people with Alzheimer's disease. The goal is to find out if AXS-05 can balance brain chemicals to calm agitation and improve behavior. AXS-05, a combination of dextromethorphan and bupropion, is being investigated for its potential to treat agitation in Alzheimer's disease and has shown promise in early clinical trials.
Image of Clinical Research Site in Santa Ana, United States.

AXS-05

Behavioural Intervention

Recruiting1 awardPhase 3
This trial is testing a new drug for Alzheimer's patients who experience agitation. The goal is to see if it is safe and effective long-term.
Image of Center for Cognitive Health in Portland, United States.

ATH-1017

Recruiting1 awardPhase 2 & 3
This trial is testing the safety and tolerability of fosgonimeton in Alzheimer's patients who have completed other studies.
Image of University of Alabama, Birmingham in Birmingham, United States.

Lecanemab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 3
This trial is testing lecanemab, a drug aimed at improving memory and thinking skills in people with early signs of Alzheimer's disease. The drug works by reducing amyloid plaques in the brain, which are believed to contribute to Alzheimer's. Researchers want to see if lecanemab is effective over several years.
Image of University of Alabama Birmingham in Birmingham, United States.

JNJ-63733657 +1 More

Monoclonal Antibodies

Recruiting0 awardsPhase 2
This trial is testing a new drug called JNJ-63733657 to see if it can help slow down the worsening of symptoms in patients with Alzheimer's disease. The goal is to see if the drug can help maintain brain function and daily living skills better.
Image of Banner Alzheimer's Institute- Clinical Trials Department in Phoenix, United States.

ACU193

Monoclonal Antibodies

Recruiting0 awardsPhase 2 & 3
This trial aims to test if ACU193 infusions given every four weeks can help slow down mental and physical decline in people with early Alzheimer's disease compared to a placebo.
Image of Banner Alzheimer's Institute in Phoenix, United States.

AL002

Monoclonal Antibodies

Recruiting0 awardsPhase 2
This trial is testing whether a new drug, AL002, is effective and safe in people with early Alzheimer's disease.
Image of Clinical Research Site in Phoenix, United States.

AVP-786

Behavioural Intervention

Verified
Recruiting1 awardPhase 3
This trial tests a combination of two drugs taken by mouth to help calm severe agitation in people with Alzheimer's disease by balancing brain chemicals.
Image of Facility #1 in Birmingham, United States.

Lecanemab +1 More

Monoclonal Antibodies

Recruiting0 awardsPhase 2
This trial is testing a new drug, lecanemab, to see if it's effective in treating Alzheimer's disease. The trial will last 18 months and have interim analyses to update treatment allocation. Those who complete the trial or discontinue early will be eligible for the Extension Phase, which will last up to 60 months.
Image of Kingfisher Cooperative in Spokane, United States.

AR1001

Verified
Recruiting1 awardPhase 3
This trial tests AR1001, a medicine for early Alzheimer's Disease. It focuses on people in the early stages of Alzheimer's, aiming to improve their condition through multiple mechanisms.

Phase 3 Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.